| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.41B | 40.18B | 38.84B | 38.54B | 38.08B | 37.27B |
| Gross Profit | 8.09B | 7.95B | 8.68B | 7.29B | 6.27B | 9.04B |
| EBITDA | 6.35B | 6.11B | 6.85B | 5.92B | 4.58B | 6.99B |
| Net Income | 2.51B | 2.89B | 2.56B | 1.59B | 855.00M | 3.73B |
Balance Sheet | ||||||
| Total Assets | 76.21B | 78.46B | 77.14B | 78.68B | 74.97B | 72.80B |
| Cash, Cash Equivalents and Short-Term Investments | 7.63B | 8.11B | 7.93B | 8.74B | 7.84B | 9.01B |
| Total Debt | 15.07B | 14.40B | 16.71B | 16.55B | 16.79B | 17.45B |
| Total Liabilities | 29.21B | 28.13B | 30.74B | 33.63B | 32.73B | 30.93B |
| Stockholders Equity | 47.00B | 50.32B | 46.40B | 45.05B | 42.24B | 41.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 219.00M | 1.19B | 1.10B | -1.25B | -3.00B |
| Operating Cash Flow | 0.00 | 5.37B | 6.37B | 6.15B | 1.49B | 1.98B |
| Investing Cash Flow | 0.00 | -3.36B | -5.07B | -4.41B | -2.82B | -3.08B |
| Financing Cash Flow | 0.00 | -1.87B | -2.42B | -870.00M | 102.00M | 120.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥52.31B | 8.97 | ― | 5.04% | -6.31% | 6.66% | |
72 Outperform | ¥34.82B | 9.31 | ― | 2.37% | -1.11% | -3.98% | |
72 Outperform | ¥35.45B | 8.84 | ― | 1.90% | -0.76% | 25.33% | |
71 Outperform | ¥34.37B | 5.80 | ― | 3.84% | 3.45% | 14.22% | |
69 Neutral | ¥55.29B | 13.50 | ― | 2.92% | -5.24% | 17.53% | |
68 Neutral | ¥39.81B | 20.31 | ― | 3.77% | 10.19% | -3.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |